Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Sep 4;8:361. doi: 10.3389/fonc.2018.00361

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2018 Lin, Zhang, Zhang, Zhang, Zhou and Yan.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Kaplan-Meier survival analysis of HLA-G expression status with mAbs 4H84 or 5A6G7 in CRC patients. (A) Comparison between HLA-G_neg and HLA-G_pos with mAb 4H84 in the whole cohort of CRC patients (p = 0.250); (B) between HLA-G_neg and HLA-G_pos with mAb 5A6G7 in the whole cohort of CRC patients (p = 0.268); (C) among patient with _ΔHLA-G_neg, _ΔHLA-G_com and _ΔHLA-G_pos (p = 0.017) in the whole cohort of CRC patients. (D) between patients with HLA-G status of mAbs 5A6G7^pos4H84^neg and with mAbs 5A6G7^neg4H84^pos (p = 0.046); (E) among AJCC stage II CRC patient with _ΔHLA-G_neg, _ΔHLA-G_com and _ΔHLA-G_pos (p = 0.031); and (F) among AJCC stage III CRC patient with _ΔHLA-G_neg, _ΔHLA-G_com and _ΔHLA-G_pos (p = 0.158). Note: p-value in double-head arrow represents the comparison between subgroups of the CRC patients indicated.